Working to Eradicate Gynecologic Cancers

276 - Poster Session A
The HMG-CoA reductase inhibitor simvastatin exhibits antitumorigenic and antimetastatic effects in ovarian cancer

Saturday, March 22, 2014: 7:25 AM
West Exhibit Hall (Tampa Convention Center)
J. E. Stine, X. Han, M. Schointuch, C. Zhou, T. Gilliam, P. A. Gehrig and V. L. Bae-Jump
University of North Carolina at Chapel Hill, Chapel Hill, NC
 
See more of: Poster Session A
See more of: Poster Session
<< Previous Presentation | Next Presentation >>